{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:37:03Z","timestamp":1790667423631,"version":"4.1.0"},"reference-count":105,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T00:00:00Z","timestamp":1561420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI120756"],"award-info":[{"award-number":["AI120756"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.01457","type":"journal-article","created":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T13:59:52Z","timestamp":1561471192000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":85,"title":["Influenza and Antibody-Dependent Cellular Cytotoxicity"],"prefix":"10.3389","volume":"10","author":[{"given":"Tarra A.","family":"Von Holle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Anthony","family":"Moody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,6,25]]},"reference":[{"key":"B1","unstructured":"Influenza Update \u2013 331.2018"},{"key":"B2","doi-asserted-by":"publisher","first-page":"D49","DOI":"10.1016\/j.vaccine.2008.07.039","article-title":"The biology of influenza viruses","volume":"26","author":"Bouvier","year":"2008","journal-title":"Vaccine."},{"key":"B3","doi-asserted-by":"publisher","first-page":"28411","DOI":"10.1074\/jbc.R110.117531","article-title":"Influenza A virus polymerase: structural insights into replication and host adaptation mechanisms","volume":"285","author":"Boivin","year":"2010","journal-title":"J Biol Chem."},{"key":"B4","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.coviro.2015.03.006","article-title":"Influenza virus antigenicity and broadly neutralizing epitopes","volume":"11","author":"Air","year":"2015","journal-title":"Curr Opin Virol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1172\/JCI81104","article-title":"Focused antibody response to influenza linked to antigenic drift","volume":"125","author":"Huang","year":"2015","journal-title":"J Clin Invest."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2842","DOI":"10.1016\/j.celrep.2015.11.063","article-title":"Immunogenic stimulus for germline precursors of antibodies that engage the influenza hemagglutinin receptor-binding site","volume":"13","author":"Schmidt","year":"2015","journal-title":"Cell Rep."},{"key":"B7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3201\/eid1201.051254","article-title":"Influenza pandemics of the 20th century","volume":"12","author":"Kilbourne","year":"2006","journal-title":"Emerg Infect Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3201\/eid1201.051371","article-title":"Non-pharmaceutical interventions for pandemic influenza, national and community measures","volume":"12","author":"Bell","year":"2006","journal-title":"Emerg Infect Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1093\/aje\/kwv293","article-title":"What transmission precautions best control influenza spread in a hospital?","volume":"183","author":"Blanco","year":"2016","journal-title":"Am J Epidemiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6602a1","article-title":"Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices - United States, 2017-18 influenza season","volume":"66","author":"Grohskopf","year":"2017","journal-title":"MMWR Recomm Rep."},{"key":"B11","doi-asserted-by":"publisher","first-page":"643","DOI":"10.15585\/mmwr.mm6722a5","article-title":"Update: ACIP recommendations for the use of quadrivalent live attenuated influenza vaccine (LAIV4) - United States, 2018-19 influenza season","volume":"67","author":"Grohskopf","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"B12","doi-asserted-by":"publisher","first-page":"156","DOI":"10.15585\/mmwr.mm6705e2","article-title":"Advisory committee on immunization practices recommended immunization schedule for children and adolescents aged 18 years or younger - United States, 2018","volume":"67","author":"Robinson","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"B13","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1172\/JCI101633","article-title":"Protective effect of vaccination against induced influenza A","volume":"24","author":"Francis","year":"1945","journal-title":"J Clin Invest."},{"key":"B14","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1172\/JCI101634","article-title":"Protective effect of vaccination against induced influenza B","volume":"24","author":"Salk","year":"1945","journal-title":"J Clin Invest."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.2105\/AJPH.37.8.1013","article-title":"Experience with vaccination against influenza in the spring of 1947: a preliminary report","volume":"37","author":"Francis","year":"1947","journal-title":"Am J Public Health Nations Health."},{"key":"B16","doi-asserted-by":"publisher","first-page":"345","DOI":"10.2105\/AJPH.39.3.345","article-title":"Importance of antigenic composition of influenza virus vaccine in protecting against the natural disease; observations during the winter of 1947-1948","volume":"39","author":"Salk","year":"1949","journal-title":"Am J Public Health Nations Health."},{"key":"B17","doi-asserted-by":"publisher","first-page":"S672","DOI":"10.1093\/infdis\/136.Supplement_3.S672","article-title":"Reactogenicity and immunogenicity of bivalent influenza A and monovalent influenza B virus vaccines in high-risk children","volume":"136","author":"Allison","year":"1977","journal-title":"J Infect Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1086\/315323","article-title":"Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine","volume":"181","author":"Belshe","year":"2000","journal-title":"J Infect Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/nrd4529","article-title":"Advances in the development of influenza virus vaccines","volume":"14","author":"Krammer","year":"2015","journal-title":"Nat Rev Drug Discov."},{"key":"B20","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.ejpb.2015.05.023","article-title":"Current and next generation influenza vaccines: formulation and production strategies","volume":"94","author":"Soema","year":"2015","journal-title":"Eur J Pharm Biopharm."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1016\/j.vaccine.2009.11.043","article-title":"Epidemiological, antigenic and genetic characteristics of seasonal influenza A(H1N1), A(H3N2) and B influenza viruses: basis for the WHO recommendation on the composition of influenza vaccines for use in the 2009\u20132010 northern hemisphere season","volume":"28","author":"Barr","year":"2010","journal-title":"Vaccine."},{"key":"B22","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/1741-7015-11-153","article-title":"Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysis","volume":"11","author":"Tricco","year":"2013","journal-title":"BMC Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1093\/infdis\/jiy103","article-title":"A universal influenza vaccine: the strategic plan for the national institute of allergy and infectious diseases","volume":"218","author":"Erbelding","year":"2018","journal-title":"J Infect Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/0264-410X(94)90227-5","article-title":"Morphological and biochemical characterization of influenza vaccines commercially available in the United Kingdom","volume":"12","author":"Renfrey","year":"1994","journal-title":"Vaccine."},{"key":"B25","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/nri2206","article-title":"Fcgamma receptors as regulators of immune responses","volume":"8","author":"Nimmerjahn","year":"2008","journal-title":"Nat Rev Immunol."},{"key":"B26","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.4049\/jimmunol.119.6.2100","article-title":"Lymphocyte cytotoxicity to influenza virus-infected cells. II requirement for antibody and non-T lymphocytes","volume":"119","author":"Greenberg","year":"1977","journal-title":"J Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1093\/infdis\/148.5.785","article-title":"Antibody-dependent cell-mediated cytotoxicity against influenza virus-infected cells","volume":"148","author":"Hashimoto","year":"1983","journal-title":"J Infect Dis."},{"key":"B28","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1128\/IAI.42.1.214-218.1983","article-title":"Ability of human cord blood lymphocytes to mediate antibody-dependent cellular cytotoxicity against influenza virus-infected cells","volume":"42","author":"Hashimoto","year":"1983","journal-title":"Infect Immun."},{"key":"B29","doi-asserted-by":"publisher","first-page":"6953","DOI":"10.1128\/JVI.75.15.6953-6961.2001","article-title":"Antibody from patients with acute human immunodeficiency virus (HIV) infection inhibits primary strains of HIV type 1 in the presence of natural-killer effector cells","volume":"75","author":"Forthal","year":"2001","journal-title":"J Virol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1056\/NEJMoa1113425","article-title":"Immune-correlates analysis of an HIV-1 vaccine efficacy trial","volume":"366","author":"Haynes","year":"2012","journal-title":"N Engl J Med."},{"key":"B31","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.4049\/jimmunol.127.4.1273","article-title":"Protection of neonatal mice against herpes simplex viral infection by human antibody and leukocytes from adult, but not neonatal humans","volume":"127","author":"Kohl","year":"1981","journal-title":"J Immunol."},{"key":"B32","doi-asserted-by":"crossref","first-page":"370","DOI":"10.4049\/jimmunol.129.1.370","article-title":"Protection of neonatal mice against herpes simplex virus infection: probable in vivo antibody-dependent cellular cytotoxicity","volume":"129","author":"Kohl","year":"1982","journal-title":"J Immunol."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00411-17","article-title":"Monoclonal antibodies, derived from humans vaccinated with the RV144 HIV vaccine containing the HVEM binding domain of herpes simplex virus (HSV) glycoprotein D, neutralize HSV infection, mediate antibody-dependent cellular cytotoxicity, and protect mice from ocular challenge with HSV-1","volume":"91","author":"Wang","year":"2017","journal-title":"J Virol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.chom.2018.07.009","article-title":"A role for Fc function in therapeutic monoclonal antibody-mediated protection against ebola virus","volume":"24","author":"Gunn","year":"2018","journal-title":"Cell Host Microbe."},{"key":"B35","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.cell.2018.07.033","article-title":"Systematic analysis of monoclonal antibodies against ebola virus GP defines features that contribute to protection","volume":"174","author":"Saphire","year":"2018","journal-title":"Cell."},{"key":"B36","doi-asserted-by":"publisher","first-page":"5598","DOI":"10.4049\/jimmunol.172.9.5598","article-title":"Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity","volume":"172","author":"Jegerlehner","year":"2004","journal-title":"J Immunol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nm.3443","article-title":"Broadly neutralizing hemagglutinin stalk-specific antibodies require FcgammaR interactions for protection against influenza virus in vivo","volume":"20","author":"DiLillo","year":"2014","journal-title":"Nat Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.cell.2019.03.048","article-title":"Antibodies to a conserved influenza head interface epitope protect by an IgG subtype-dependent mechanism","volume":"177","author":"Watanabe","year":"2019","journal-title":"Cell."},{"key":"B39","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.bbamem.2010.04.015","article-title":"Influenza M2 proton channels","volume":"1808","author":"Pielak","year":"2011","journal-title":"Biochim Biophys Acta."},{"key":"B40","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1073\/pnas.87.2.786","article-title":"Independent and disparate evolution in nature of influenza A virus hemagglutinin and neuraminidase glycoproteins","volume":"87","author":"Kilbourne","year":"1990","journal-title":"Proc Natl Acad Sci USA."},{"key":"B41","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1128\/IAI.20.3.640-645.1978","article-title":"Lymphocyte cytotoxicity to influenza virus-infected cells: response to vaccination and virus infection","volume":"20","author":"Greenberg","year":"1978","journal-title":"Infect Immun."},{"key":"B42","doi-asserted-by":"publisher","first-page":"4622","DOI":"10.1073\/pnas.76.9.4622","article-title":"Cell cytotoxicity due to specific influenza antibody production in vitro after recent influenza antigen stimulation","volume":"76","author":"Greenberg","year":"1979","journal-title":"Proc Natl Acad Sci USA."},{"key":"B43","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/jmv.1890060303","article-title":"Antibody reactive in antibody-dependent cell-mediated cytotoxicity following influenza virus vaccination","volume":"6","author":"Vella","year":"1980","journal-title":"J Med Virol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"469","DOI":"10.4049\/jimmunol.1400432","article-title":"Influenza-specific antibody-dependent cellular cytotoxicity: toward a universal influenza vaccine","volume":"193","author":"Jegaskanda","year":"2014","journal-title":"J Immunol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1038\/s41564-017-0011-8","article-title":"Broadly protective murine monoclonal antibodies against influenza B virus target highly conserved neuraminidase epitopes","volume":"2","author":"Wohlbold","year":"2017","journal-title":"Nat Microbiol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1056\/NEJM197206222862502","article-title":"Association of serum anti-neuraminidase antibody with resistance to influenza in man","volume":"286","author":"Murphy","year":"1972","journal-title":"N Engl J Med."},{"key":"B47","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/infdis\/129.4.411","article-title":"Induction of partial immunity to influenza by a neuraminidase-specific vaccine","volume":"129","author":"Couch","year":"1974","journal-title":"J Infect Dis."},{"key":"B48","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1093\/infdis\/jis935","article-title":"Antibody correlates and predictors of immunity to naturally occurring influenza in humans and the importance of antibody to the neuraminidase","volume":"207","author":"Couch","year":"2013","journal-title":"J Infect Dis."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1093\/infdis\/jiv195","article-title":"Antibody to influenza virus neuraminidase: an independent correlate of protection","volume":"212","author":"Monto","year":"2015","journal-title":"J Infect Dis."},{"key":"B50","doi-asserted-by":"publisher","first-page":"e00417","DOI":"10.1128\/mBio.00417-16","article-title":"Evaluation of antihemagglutinin and antineuraminidase antibodies as correlates of protection in an influenza A\/H1N1 virus healthy human challenge model","volume":"7","author":"Memoli","year":"2016","journal-title":"MBio."},{"key":"B51","doi-asserted-by":"publisher","first-page":"e02332","DOI":"10.1128\/mBio.02332-17","article-title":"NAction! How can neuraminidase-based immunity contribute to better influenza virus vaccines?","volume":"9","author":"Krammer","year":"2018","journal-title":"MBio."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.4049\/jimmunol.0902147","article-title":"Universal vaccine based on ectodomain of matrix protein 2 of influenza A: Fc receptors and alveolar macrophages mediate protection","volume":"186","author":"El Bakkouri","year":"2011","journal-title":"J Immunol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"e02500","DOI":"10.1128\/JVI.02500-16","article-title":"Hierarchical and redundant roles of activating fcgammars in protection against influenza disease by M2e-specific IgG1 and IgG2a antibodies","volume":"91","author":"Van den Hoecke","year":"2017","journal-title":"J Virol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"5145","DOI":"10.1016\/j.vaccine.2011.05.041","article-title":"Safety and immunogenicity of a recombinant M2e-flagellin influenza vaccine (STF2.4xM2e) in healthy adults","volume":"29","author":"Turley","year":"2011","journal-title":"Vaccine."},{"key":"B55","doi-asserted-by":"publisher","first-page":"e59081","DOI":"10.1371\/journal.pone.0059081","article-title":"M2e-displaying virus-like particles with associated RNA promote T helper 1 type adaptive immunity against influenza A","volume":"8","author":"Ibanez","year":"2013","journal-title":"PLoS ONE."},{"key":"B56","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1099\/0022-1317-83-4-723","article-title":"The influenza virus nucleoprotein: a multifunctional RNA-binding protein pivotal to virus replication","volume":"83","author":"Portela","year":"2002","journal-title":"J Gen Virol."},{"key":"B57","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.4049\/jimmunol.126.5.1814","article-title":"Expression of influenza A virus internal antigens on the surface of infected P815 cells","volume":"126","author":"Yewdell","year":"1981","journal-title":"J Immunol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1099\/jgv.0.000518","article-title":"Cross-protective potential of anti-nucleoprotein human monoclonal antibodies against lethal influenza A virus infection","volume":"97","author":"Fujimoto","year":"2016","journal-title":"J Gen Virol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1093\/infdis\/jiw629","article-title":"Induction of H7N9-cross-reactive antibody-dependent cellular cytotoxicity antibodies by human seasonal influenza A viruses that are directed toward the nucleoprotein","volume":"215","author":"Jegaskanda","year":"2017","journal-title":"J Infect Dis."},{"key":"B60","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.ebiom.2016.04.029","article-title":"What lies beneath: antibody dependent natural killer cell activation by antibodies to internal influenza virus proteins","volume":"8","author":"Vanderven","year":"2016","journal-title":"EBioMed."},{"key":"B61","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.smim.2004.08.005","article-title":"Evolution of isotype switching","volume":"16","author":"Stavnezer","year":"2004","journal-title":"Semin Immunol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.vetimm.2004.06.008","article-title":"Fc receptors in livestock species","volume":"102","author":"Kacskovics","year":"2004","journal-title":"Vet Immunol Immunopathol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1172\/JCI84428","article-title":"Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection","volume":"126","author":"DiLillo","year":"2016","journal-title":"J Clin Invest."},{"key":"B64","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.chom.2016.05.014","article-title":"Both neutralizing and non-neutralizing human H7N9 influenza vaccine-induced monoclonal antibodies confer protection","volume":"19","author":"Henry Dunand","year":"2016","journal-title":"Cell Host Microbe."},{"key":"B65","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.virol.2016.08.010","article-title":"Cross-protective efficacies of highly-pathogenic avian influenza H5N1 vaccines against a recent H5N8 virus","volume":"498","author":"Park","year":"2016","journal-title":"Virology."},{"key":"B66","doi-asserted-by":"publisher","first-page":"e1005578","DOI":"10.1371\/journal.ppat.1005578","article-title":"Broadly-reactive neutralizing and non-neutralizing antibodies directed against the H7 influenza virus hemagglutinin reveal divergent mechanisms of protection","volume":"12","author":"Tan","year":"2016","journal-title":"PLoS Pathog."},{"key":"B67","doi-asserted-by":"publisher","first-page":"e01463","DOI":"10.1128\/mBio.01463-17","article-title":"Influenza virus hemagglutinin stalk-specific antibodies in human serum are a surrogate marker for in vivo protection in a serum transfer mouse challenge model","volume":"8","author":"Jacobsen","year":"2017","journal-title":"MBio."},{"key":"B68","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3389\/fimmu.2017.00317","article-title":"Antibody-dependent cell-mediated cytotoxicity epitopes on the hemagglutinin head region of pandemic H1N1 influenza virus play detrimental roles in H1N1-infected mice","volume":"8","author":"Ye","year":"2017","journal-title":"Front Immunol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1016\/j.bbrc.2018.07.129","article-title":"Vaccine based on antibody-dependent cell-mediated cytotoxicity epitope on the H1N1 influenza virus increases mortality in vaccinated mice","volume":"503","author":"Wang","year":"2018","journal-title":"Biochem Biophys Res Commun."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.3390\/ijms18081650","article-title":"Evolution of influenza A virus by mutation and Re-assortment","volume":"18","author":"Shao","year":"2017","journal-title":"Int J Mol Sci."},{"key":"B71","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/82_2014_391","article-title":"Pathogenesis and vaccination of influenza A virus in swine","volume":"385","author":"Rajao","year":"2014","journal-title":"Curr Top Microbiol Immunol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.vaccine.2009.09.130","article-title":"Swine influenza matrix 2 (M2) protein contributes to protection against infection with different H1 swine influenza virus (SIV) isolates","volume":"28","author":"Kitikoon","year":"2009","journal-title":"Vaccine."},{"key":"B73","doi-asserted-by":"publisher","first-page":"200ra114","DOI":"10.1126\/scitranslmed.3006366","article-title":"Vaccine-induced anti-HA2 antibodies promote virus fusion and enhance influenza virus respiratory disease","volume":"5","author":"Khurana","year":"2013","journal-title":"Sci Transl Med."},{"key":"B74","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.1016\/j.vaccine.2011.01.082","article-title":"Enhanced pneumonia and disease in pigs vaccinated with an inactivated human-like (delta-cluster) H1N2 vaccine and challenged with pandemic 2009 H1N1 influenza virus","volume":"29","author":"Gauger","year":"2011","journal-title":"Vaccine."},{"key":"B75","doi-asserted-by":"publisher","first-page":"200fs234","DOI":"10.1126\/scitranslmed.3007118","article-title":"Universal flu vaccines: primum non nocere","volume":"5","author":"Crowe","year":"2013","journal-title":"Sci Transl Med."},{"key":"B76","doi-asserted-by":"publisher","first-page":"865","DOI":"10.3389\/fimmu.2018.00865","article-title":"Therapeutic Administration of broadly neutralizing FI6 antibody reveals lack of interaction between human IgG1 and Pig Fc receptors","volume":"9","author":"Morgan","year":"2018","journal-title":"Front Immunol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"3268","DOI":"10.1128\/JVI.02481-15","article-title":"Hemagglutinin stalk immunity reduces influenza virus replication and transmission in ferrets","volume":"90","author":"Nachbagauer","year":"2015","journal-title":"J Virol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/nm.3927","article-title":"Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection","volume":"21","author":"Yassine","year":"2015","journal-title":"Nat Med."},{"key":"B79","doi-asserted-by":"publisher","first-page":"eaam5752","DOI":"10.1126\/scitranslmed.aam5752","article-title":"A multimechanistic antibody targeting the receptor binding site potently cross-protects against influenza B viruses","volume":"9","author":"Shen","year":"2017","journal-title":"Sci Transl Med."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.3390\/v20801530","article-title":"Animal models for influenza virus pathogenesis and transmission","volume":"2","author":"Bouvier","year":"2010","journal-title":"Viruses."},{"key":"B81","doi-asserted-by":"publisher","first-page":"5512","DOI":"10.1128\/JVI.03030-12","article-title":"Antibody-dependent cellular cytotoxicity is associated with control of pandemic H1N1 influenza virus infection of macaques","volume":"87","author":"Jegaskanda","year":"2013","journal-title":"J Virol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"e0181738","DOI":"10.1371\/journal.pone.0181738","article-title":"A modified vaccinia Ankara vaccine vector expressing a mosaic H5 hemagglutinin reduces viral shedding in rhesus macaques","volume":"12","author":"Florek","year":"2017","journal-title":"PLoS ONE."},{"key":"B83","doi-asserted-by":"publisher","first-page":"13418","DOI":"10.1128\/JVI.01219-14","article-title":"Modified vaccinia virus Ankara encoding influenza virus hemagglutinin induces heterosubtypic immunity in macaques","volume":"88","author":"Florek","year":"2014","journal-title":"J Virol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.antiviral.2014.08.016","article-title":"Evaluation of a fully human monoclonal antibody against multiple influenza A viral strains in mice and a pandemic H1N1 strain in nonhuman primates","volume":"111","author":"Song","year":"2014","journal-title":"Antiviral Res."},{"key":"B85","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1097\/COH.0000000000000051","article-title":"The role of Fc receptors in HIV infection and vaccine efficacy","volume":"9","author":"Cocklin","year":"2014","journal-title":"Curr Opin HIV AIDS."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1093\/infdis\/jiv181","article-title":"High antibody-dependent cellular cytotoxicity antibody titers to H5N1 and H7N9 avian influenza A viruses in healthy US adults and older children","volume":"212","author":"Terajima","year":"2015","journal-title":"J Infect Dis."},{"key":"B87","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1093\/infdis\/jiu334","article-title":"Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity in intravenous immunoglobulin as a potential therapeutic against emerging influenza viruses","volume":"210","author":"Jegaskanda","year":"2014","journal-title":"J Infect Dis."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1093\/infdis\/jit294","article-title":"Age-associated cross-reactive antibody-dependent cellular cytotoxicity toward 2009 pandemic influenza A virus subtype H1N1","volume":"208","author":"Jegaskanda","year":"2013","journal-title":"J Infect Dis."},{"key":"B89","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1089\/vim.2014.0061","article-title":"Relationship of preexisting influenza hemagglutination inhibition, complement-dependent lytic, and antibody-dependent cellular cytotoxicity antibodies to the development of clinical illness in a prospective study of A(H1N1)pdm09 Influenza in children","volume":"27","author":"Co","year":"2014","journal-title":"Viral Immunol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1099\/jgv.0.000552","article-title":"Influenza virus A(H1N1)2009 antibody-dependent cellular cytotoxicity in young children prior to the H1N1 pandemic","volume":"97","author":"Mesman","year":"2016","journal-title":"J Gen Virol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"e92750","DOI":"10.1172\/jci.insight.92750","article-title":"Fc functional antibodies in humans with severe H7N9 and seasonal influenza","volume":"2","author":"Vanderven","year":"2017","journal-title":"JCI Insight."},{"key":"B92","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1093\/infdis\/jix554","article-title":"Antibody-dependent cellular cytotoxicity responses to seasonal influenza vaccination in older adults","volume":"217","author":"Vanderven","year":"2017","journal-title":"J Infect Dis."},{"key":"B93","doi-asserted-by":"publisher","first-page":"e00502","DOI":"10.1128\/mSphere.00502-17","article-title":"Vaccination with a recombinant H7 hemagglutinin-based influenza virus vaccine induces broadly reactive antibodies in humans","volume":"2","author":"Stadlbauer","year":"2017","journal-title":"mSphere."},{"key":"B94","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1093\/infdis\/jiy214","article-title":"Induction of cross-clade antibody and T-cell responses by a modified vaccinia virus ankara-based influenza A(H5N1) vaccine in a randomized phase 1\/2a clinical trial","volume":"218","author":"de Vries","year":"2018","journal-title":"J Infect Dis."},{"key":"B95","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1038\/s41467-018-04704-9","article-title":"A multifunctional human monoclonal neutralizing antibody that targets a unique conserved epitope on influenza HA","volume":"9","author":"Bangaru","year":"2018","journal-title":"Nat Commun."},{"key":"B96","doi-asserted-by":"publisher","first-page":"14234","DOI":"10.1038\/ncomms14234","article-title":"A broadly protective therapeutic antibody against influenza B virus with two mechanisms of action","volume":"8","author":"Chai","year":"2017","journal-title":"Nat Commun."},{"key":"B97","doi-asserted-by":"publisher","first-page":"11931","DOI":"10.1073\/pnas.1609316113","article-title":"Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus","volume":"113","author":"He","year":"2016","journal-title":"Proc Natl Acad Sci USA."},{"key":"B98","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3389\/fimmu.2016.00399","article-title":"HA antibody-mediated FcgammaRIIIa activity is both dependent on fcr engagement and interactions between HA and sialic acids","volume":"7","author":"Cox","year":"2016","journal-title":"Front Immunol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"E5944","DOI":"10.1073\/pnas.1613225113","article-title":"Optimal activation of Fc-mediated effector functions by influenza virus hemagglutinin antibodies requires two points of contact","volume":"113","author":"Leon","year":"2016","journal-title":"Proc Natl Acad Sci USA."},{"key":"B100","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.chom.2017.08.011","article-title":"A potent germline-like human monoclonal antibody targets a pH-sensitive epitope on H7N9 influenza hemagglutinin","volume":"22","author":"Yu","year":"2017","journal-title":"Cell Host Microbe."},{"key":"B101","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/infdis\/jix546","article-title":"Primary human influenza B virus infection induces cross-lineage hemagglutinin stalk-specific antibodies mediating antibody-dependent cellular cytoxicity","volume":"217","author":"de Vries","year":"2017","journal-title":"J Infect Dis."},{"key":"B102","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.cell.2019.04.011","article-title":"A site of vulnerability on the influenza virus hemagglutinin head domain trimer interface","volume":"177","author":"Bangaru","year":"2019","journal-title":"Cell."},{"key":"B103","doi-asserted-by":"publisher","first-page":"P827","DOI":"10.1016\/j.chom.2019.04.003","article-title":"Influenza antigen engineering focuses immune responses to a subdominant but broadly protective viral epitope","volume":"25","author":"Bajic","year":"2019","journal-title":"Cell Host Microbe."},{"key":"B104","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1093\/infdis\/jiw262","article-title":"Generation and protective ability of influenza virus-specific antibody-dependent cellular cytotoxicity in humans elicited by vaccination, natural infection, and experimental challenge","volume":"214","author":"Jegaskanda","year":"2016","journal-title":"J Infect Dis."},{"key":"B105","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1128\/CVI.00396-10","article-title":"Prevalence of antibodies against seasonal influenza A and B viruses in children in Netherlands","volume":"18","author":"Bodewes","year":"2011","journal-title":"Clin Vaccine Immunol."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01457\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T18:58:36Z","timestamp":1694977116000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01457\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,25]]},"references-count":105,"alternative-id":["10.3389\/fimmu.2019.01457"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.01457","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,25]]},"article-number":"1457"}}